Top compounds associated with response to SLC39A1


Feature Type Standardized
Nominal ANOVA
mRNA selumetinib:navitoclax (8:1 mol/mol) CTRPv2 pan-cancer AAC -0.036 0.3
mRNA FGIN-1-27 CTRPv2 pan-cancer AAC 0.078 0.3
mRNA JW-55 CTRPv2 pan-cancer AAC 0.091 0.3
mRNA SR8278 CTRPv2 pan-cancer AAC 0.14 0.3
mRNA QS11 GDSC1000 pan-cancer AAC -0.037 0.3
mRNA BMS-536924 GDSC1000 pan-cancer AAC -0.034 0.3
mRNA Dasatinib FIMM pan-cancer AAC -0.22 0.3
mRNA BRD1835 CTRPv2 pan-cancer AAC -0.037 0.3
mRNA PD-0325901 CCLE pan-cancer AAC 0.049 0.3
mRNA navitoclax:birinapant (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.035 0.3
Download CSV